39
Are bone scans necessary in men with low prostate specific antigen levels following localized therapy?
Warren KS, Chodak GW, See WA, Iversen P, McLeod D, Wirth M, Morris C, Armstrong J
Journal of Urology 2006
Publications
All trial summaries
Read abstracts below
38
Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer: updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years
Iversen P, Johansson J-E, Lodding P, Kylmälä T, Lundmo P, Klarskov P, Tammela T, Tasdemir I, Morris T, Amstrong J
Scand J Urol Nephrol 2006
SPCG-6
37
Prognostic value of serum PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma
Brasso K, Christensen IJ, Johansen JS, Teisner B, Garnero P, Price PA, Iversen P
The Prostate 2006
36
The third analysis of the bicalutamide early prostate cancer programme
Iversen P
British Journal of Urology International 2006
35
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
Mcleod,David G.; Iversen,Peter; See,William A.; Morris,Thomas; Armstrong,Jon; Wirth,Manfred P.; on behalf of the Casodex Early Prostate Cancer Trialists' Group
BJU Inter 2006
34
Bicalutamide (‘Casodex’) 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme
Tyrrell CJ, Payne H, See WA, McLeod DG, Wirth MP, Iversen P, Armstrong J, Morris C
Radiother Oncol. 2005
33
Inguinal hernia in stage M0 prostate cancer: a comparison of incidence in men treated with and without radical retropubic prostatectomy – an analysis of 1105 patients
Stranne J, Hugosson J, Iversen P, Morris T, Lodding P
Urology 2005
32
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson A1, Holmberg L, Ruutu M, Häggman M, Andersson SO, Bratell S, Spångberg A, Busch C, Nordling S, Garmo H, Palmgren J, Adami HO, Norlén BJ, Johansson JE; Scandinavian Prostate Cancer Group Study No. 4.
N Engl J Med. 2005
SPCG-4
31
Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: Results from the scandinavian prostate cancer group study 5
Jønler M, Nielsen OS, Groenvold M, Hedlund PO, Damber L, Hedelin H, Waldén M, & the Scandinavian Prostate Cancer Group Study 5 Study Group
Scand J Urol Nephrol. 2005
SPCG-5
30
Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from The Scandinavian Prostate Cancer Group Study number 6
Iversen P, Johansson Jan-Erik, Lodding P, Lukkarinen O, Lundmo P, Klarskov P, Tammela TLJ, Tasdemir I, Morris T, Carrol K
J Urol 2004
SPCG-6